Esophageal

HCRN-ESO17-325

A Phase II Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Homologous Recombination (HR) Defective or Loss of Heterozygosity (LOH) High Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma
Status
Closed
Cancer Types
Esophageal
Locations

BTCRC-ESO14-012

A Phase II Study Evaluating Safety and Efficacy of Durvalumab (MEDI4736) Following Multi-modality Therapy in Esophageal Cancer: Big Ten Cancer Research Consortium BTCRC-ESO14-012
Status
Closed
Cancer Types
Esophageal
Locations

BTCRC-GI18-149

Phase II Study of the Combination of Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149
Status
Closed
Cancer Types
Esophageal
Locations

GI06-112

A Phase II Study of Sunitinib Malate (Sutent®) With Paclitaxel (Taxol®) in Patients With Advanced Esophageal Cancer
Status
Closed
Cancer Types
Esophageal
Locations

GI05-92

A Pilot Study With Cetuximab and Radiation Therapy for Patients With Surgically Resectable Esophageal and GE Junction Carcinomas: Hoosier Oncology Group Study (GI05-92)
Status
Closed
Cancer Types
Esophageal
Locations

HCRN-GI02-38

A Phase II Study of Capecitabine plus Docetaxel Combination in Patients with Esophageal/Gastric Cancer
Status
Closed
Cancer Types
Esophageal
Locations

HCRN-GI00-16

A Phase II Study of Cisplatin, 5-Fluorouracil (5-FU), Radiation Therapy and Celecoxib for Resectable Esophageal Cancer – HOG GI 00-16
Status
Closed
Cancer Types
Esophageal
Locations